BioNxt Solutions Inc. (BNXTF)
OTCMKTS · Delayed Price · Currency is USD
0.7500
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
BioNxt Solutions Market Cap
BioNxt Solutions has a market cap or net worth of $86.81 million as of August 28, 2025. Its market cap has increased by 254.74% in one year.
Market Cap
86.81M
Enterprise Value
91.40M
Revenue
15.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
Market Cap Chart
Since August 6, 2019, BioNxt Solutions's market cap has increased from 35.59M to 86.81M, an increase of 143.90%. That is a compound annual growth rate of 15.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 86.81M | 189.86% |
| Dec 31, 2024 | 29.95M | -24.03% |
| Dec 29, 2023 | 39.42M | -0.85% |
| Dec 30, 2022 | 39.76M | -40.00% |
| Dec 31, 2021 | 66.27M | -27.46% |
| Dec 31, 2020 | 91.36M | 152.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 838.96M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 654.83M |
| Elite Pharmaceuticals | 610.28M |
| CytoDyn | 396.18M |
| Northwest Biotherapeutics | 390.55M |
| American Oncology Network | 359.30M |